Medical Cannabis for Alzheimer's disease
Understanding potential benefits, risks, and clinical support
How Cannabis Interacts with the Alzheimer's Brain
The brain has an endocannabinoid system (ECS) that is involved in regulating memory, inflammation, and neural signaling. In Alzheimer’s disease, disruption of this system may contribute to cognitive decline. Cannabinoids such as CBD and THC interact with ECS receptors, potentially influencing neuroinflammation and neurotransmitter balance.
About Alzheimer's Disease
- Alzheimer’s is a progressive neurological disease.
- Affects memory, cognition, and daily function
- No known cure, focus on symptom support
Cannabis Compounds: CBD & THC
CBD
Anti-inflammatory & neuroprotective properties
THC
May improve mood & appetite
Research Summary
Emerging studies exploring symptom management potential
Potential Benefits for Alzheimer's
Discuss risks, benefits, and personalized guidance.
Memory Support
May help slow cognitive decline
Neuroinflammation
May reduce brain inflammation
Endocannabinoid System
Interacts with brain's receptors to support balance
Sleep & Appetite
May support better sleep and appetite
Can Medical Cannabis Slow the Progression of Alzheimer's Disease?
There is ample research to support medical marijuanas ability to alleviate many common Alzheimers disease symptoms, but can it slow the progress of the disease itself? Initial research in this area is promising.
One preclinical study published in the Journal of Alzheimers disease showed that THC, one of the main compounds in marijuana, can slow the production of beta-amyloid, which contributes to the progression of Alzheimers disease.
THC and CBD, another primary chemical compound in marijuana, are also known anti-inflammatories. As brain inflammation may contribute to the progression of Alzheimers disease, reducing inflammation could help slow the progression of the disease.